You searched for "AMD"
Management of ocular surface disease
3 February 2023
| Jonathan Chan
|
Cornea / External Eye Disease
|
conjunctiva, cornea, drugs, inflammation
This is a retrospective study of patients with ocular surface disease (OSIDs) treated with IKERVIS in a single centre between 2016 to 2019 with at least six months follow-up. Clinical outcome was defined as successful (resolved or stable disease), active...
Real-world experience of using ciclosporin-A 0.1% in the management of ocular surface inflammatory diseases
3 April 2023
| Kurt Spiteri Cornish
|
Cornea / External Eye Disease
|
conjunctiva, cornea, drugs, inflammation
This is a retrospective study of patients with ocular surface inflammatory diseases (OSIDs) treated with IKERVIS in a single centre between 2016 to 2019 with at least six months follow-up. Clinical outcome was defined as successful (resolved or stable disease),...
Clinical relevance of the anatomic classification of neovascular age-related macular degeneration
The author explains why an OCT-based classification of neovascular AMD is needed and how these neovascular subtypes may help to predict patients’ long-term visual outcome. Age-related macular degeneration (AMD) is a chronic and progressive neurodegenerative process involving the macula in...Eye News to partner with AOP Young Ophthalmologists Program
25 August 2021
We are delighted to announce our partnership with the AOP (Advanced Ophthalmologic Practice) Academy Young Ophthalmologists event 'Retina: How to avoid false friends'.
Importing iron to the retina
1 October 2017
| Graham Wallace
|
Retina / Uvea / Vitreous
|
Age-related macular degeneration (AMD), Ceruloplasmi, Hepcidin, Hephaestin, Iron, Retina, Zip14, Zip8
In the retina, iron is particularly critical for the visual phototransduction cascade. In the retinal pigment epithelium (RPE), RPE65 activity leads to 11-cis-retinaldehyde, the photosensitive component of rhodopsin production and iron containing enzymes are necessary for disc replacement in photoreceptor...
Macula re-attachment following intravitreal ranibizumab in rhegmatogenous retinal detachment
1 February 2015
| Rubina Rahman, Egle Rostron, Kamron Khan
|
Ophthalmology, Retina / Uvea / Vitreous
Ranibizumab (Lucentis) is a vascular endothelial growth factor inhibitor (anti-VEGF) used for treatment of choroidal neovascular membrane [1]. We report a case where macula off inferior rhegmatogenous retinal detachment was misdiagnosed as wet age-related macular degeneration (AMD) and three intravitreal...
Does amniotic membrane transplant improve outcomes in chemical injuries?
1 April 2019
| Tasmin Berman
|
Cornea / External Eye Disease
This single centre, randomised, parallel-controlled clinical trial compared the outcomes of patients with Roper-Hall grade IV ocular chemical injury that had conventional treatment vs. combined medical treatment and amniotic membrane transplantation (AMT). They followed up 60 patients between August 2006...
Hot debates in medical retina and imaging: Perspectives from the Controversies in Ophthalmology 2020 virtual conference
Controversies in medical retina and imaging were debated during the Controversies in Ophthalmology 2020 virtual conference held during two mid-day scientific sessions on 27 and 28 March 2020. The author recounts key perspectives and presents viewpoint recommendations from the Vision...Amniotic membrane transplantation for SJS/TEN
1 February 2022
| Jonathan Chan
|
Cornea / External Eye Disease
|
Ocular surface, Treatment Surgery.
This is a retrospective study of consecutive patients who underwent amniotic membrane transplantation (AMT) in the acute stage of Stevens-Johnson syndrome (SJS) / toxic epidermal necrolysis (TEN) from Toronto, Canada, between 2009 and 2018 and had more than three months...
Technology in ophthalmology – a promising future and what we need to know about the regulations
1 October 2017
| Priya Nidamanuri, Magdalena Popiela
|
Cataract and Refractive, Cornea / External Eye Disease, Glaucoma, Imaging, Ophthalmology, Optometry, Orbit, Retina / Uvea / Vitreous, AMD
Undoubtedly, ophthalmology is one of the greatest sources of inspiration for technological progress in medicine. Thus far, we have seen remarkable advancements in the technology used by ophthalmologists across all subspecialties. From simplifying common procedures, to treating previously incurable conditions,...
Simulating the visual impairment symptoms of age-related macular degeneration in virtual reality
5 June 2023
| Cameron R M Wilson, Ian Underwood, Baljean Dhillon (Prof)
|
AMD
A new virtual reality application visually simulates age-related macular degeneration and demonstrates its progression over time including some Charles Bonnet syndrome hallucinations. Introduction Age-related macular degeneration (AMD) is the leading cause of blindness in developed countries with the prevalence of...